2 defensive stocks looking attractive since recent falls

These defensive dividend growers are on sale.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Some of the more defensive firms on the London stock market are showing weaker share prices over the last few weeks, such as Hikma Pharmaceuticals (LSE: HIK) and Britvic (LSE: BVIC).

In some ways, that’s not surprising as many have enjoyed a good run-up over an extended period stretching into years.

Why these two are defensive 

Firms tend to earn the label ‘defensive’ if they have businesses with evergreen characteristics. Economic cycles, recessions and slowdowns tend to effect such businesses less than companies with more cyclical operations.

I think one of the main reasons a firm’s business exhibits defensive traits is because its goods and services often have a short life. Therefore, customers use up their purchase quickly and return to buy more, repeatedly. On top of that, defensive firms often deal in products deemed ‘essential’ by many users.

Hikma Pharmaceuticals’ business, providing generic and branded medicines to patients around the world, is a good example. People don’t tend to skip their medical treatments and medicines tend to be used up within a short time. Because of that, the company has built up an impressive record of cash flow, which supports profits.

Meanwhile, Britvic’s soft drinks business also supplies products with a short life. The power behind the firm’s success is found in its strong, well-known brands such as J2O, 7up, Robinsons and Tango. Customers’ brand loyalty seems to drive consistent cash inflows for Britvic and, just like Hikma Pharmaceuticals, the company has a decent record of cash flow supporting profits.

Uncertain times

To me, the crux of the case for investing in these two firms is in their ability to generate cash whatever the economic weather. If they keep generating cash then they can keep paying a dividend, and I think the niches they occupy in their sectors leaves them well placed to do that.

Defensive firms like Hikma Pharmaceuticals and Britvic can be popular with investors when interest rates are low and there is a lot of economic uncertainty in the air. The dividend yield available from many defensive firms can beat the rate of interest from many bank accounts. Investors have been buying the defensives, and price-to-earnings (P/E) ratings have risen with share prices as a result of all that buying.

However, recent events such as Britain’s vote to leave the European Union and the election of Donald Trump in the US seem to have led to a change in investors’ expectations for the macroeconomic environment, and some investors seem to be rotating out of defensive shares into more cyclical investment.

Decent long-term prospects

Hikma Pharmaceuticals and Britivic have seen their share prices ease off over recent weeks, but the directors of both firms seem optimistic about the longer-term prospects for their companies. 

At a share price around 1,651p, Hikma Pharmaceuticals’ forward yield runs at just over 1.5% for 2017 and forward earnings are expected to cover the payment an impressive five times. With the shares at 547p, Britvic’s forward yield is around 4.4% with the payout covered almost twice by forward earnings.

I think right now looks like a good time to research these two defensive dividend growers with a view to buying some of their shares for the long haul.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold has no position in any shares mentioned. The Motley Fool UK has recommended Britvic and Hikma Pharmaceuticals. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Unilever shares are flying! Time to buy at a 21% ‘discount’?

Unilever shares have been racing higher this week after a one-two punch of news from the company. Here’s whether I…

Read more »

artificial intelligence investing algorithms
Market Movers

The Microsoft share price surges after results. Is this the best AI stock to buy?

Jon Smith flags up the jump in the Microsoft share price after the latest results showed strong demand for AI…

Read more »

Google office headquarters
Investing Articles

A dividend announcement sends the Alphabet share price soaring. Here’s what investors need to know

As the Alphabet share price surges on the announcement of a dividend, Stephen Wright outlines what investors should really be…

Read more »

Investing Articles

Turning a £20k ISA into an annual second income of £30k? It’s possible!

This Fool UK writer is exploring how to harness the power of dividend shares and compound returns to build a…

Read more »

Midnight is celebrated along the River Thames in London with a spectacular and colourful firework display.
Investing Articles

Can I turn £10k into a £1k passive income stream with UK shares?

Everyone talks about the magical 10% mark when it comes to passive income investing, but how realistic is it to…

Read more »

Investing Articles

3 market-beating international investment funds for a Stocks and Shares ISA

It always pays to look for new ways to add extra diversity to a Stocks and Shares ISA. I think…

Read more »

Grey cat peeking out from inside a cardboard box in a house
Investing Articles

Just released: April’s latest small-cap stock recommendation [PREMIUM PICKS]

We believe the UK small-cap market offers a myriad of opportunities across a wide range of different businesses and industries.

Read more »

Fireworks display in the shape of willow at Newcastle, Co. Down , Northern Ireland at Halloween.
Investing Articles

The Anglo American share price soars to £25, but I’m not selling!

On Thursday, the Anglo American share price soared after mega-miner BHP Group made an unsolicited bid for it. But I…

Read more »